STUDIES ON STABILITY OF 2,3-DIPHENYLCYCLOPROPENONE IN CONTACT WITH WATER AND AQUEOUS NaCl SOLUTIONS. CONCLUSIONS FOR PURPOSE OF TOPICAL THERAPY OF PATIENTS WITH ALOPECIA AREATA

被引:1
作者
Wasylyszyn, Tomasz [1 ]
Borowska, Katarzyna [2 ,3 ]
机构
[1] Med Ctr Gabinet Dermatol Tomasz Wasylyszyn, 25-421 Gen Anders St, PL-00159 Warsaw, Poland
[2] Med Ctr CADERM, 87-113 Marszalkowska St, PL-00683 Warsaw, Poland
[3] Med Univ Lublin, Dept Histol & Embryol, Expt Cytol Unit, 11 Radziwilowska St, PL-20080 Lublin, Poland
来源
ACTA POLONIAE PHARMACEUTICA | 2016年 / 73卷 / 06期
关键词
alopecia areata; contact sensitizers; diphenylcyclopropenone; stability; topical immunotherapy; solvents; CUTANEOUS METASTATIC MELANOMA; DIPHENYLCYCLOPROPENONE; DIPHENCYPRONE; LYMPHOCYTES;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diphenylcyclopropenone (DCP) is a topically administered agent used for more than three decades for treatment of alopecia areata (AA). Moreover. numerous recent studies show it's efficiency in treatment of cutaneous metastatic melanoma. Despite being a potentially useful drug still very little is known about the pharmacokinetics of DCP. The authors investigated the stability of DCP solutions in propylene glycol with the addition of 0.9% aquous solution of natrium chloride (0.9% NaCl) or with water. DCP was prepared in two concentrations: 0.1% and 3%. It's stability was then measured with different proportions of 0.9% NaCl or water added and in different temperatures. Contrary to common opinion that DCP solutions arc extremely unstable, authors have found them to be relatively stable. DCP solutions with the addition of equal quantity of 0.9% NaCl decomposed slowly at the temperature of 37 degrees C but after 70 h all solutions still contained more than 80% of initial DCP. Solutions of DCP with the addition of 1% of water at the temperature of 4 degrees C are in the present study stable, containing more than 98% of initial DCP after 20 days. Authors discuss the results in spite of possible metabolism of DCP on the surface of human skin during topical immunotherapy.
引用
收藏
页码:1455 / 1460
页数:6
相关论文
共 9 条
[1]   Alopecia areata update Part I. Clinical picture, histopathology, and pathogenesis [J].
Alkhalifah, Abdullah ;
Alsantali, Adel ;
Wang, Eddy ;
McElwee, Kevin J. ;
Shapiro, Jerry .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (02) :177-188
[2]   Topical diphencyprone immunotherapy for cutaneous metastatic melanoma [J].
Damian, Diona L. ;
Shannon, Kerwin F. ;
Saw, Robyn P. ;
Thompson, John F. .
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2009, 50 (04) :266-271
[3]   Lymphocytes, neuropeptides, and genes involved in alopecia areata [J].
Gilhar, Amos ;
Paus, Ralf ;
Kalish, Richard S. .
JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (08) :2019-2027
[4]   Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes [J].
Herbst, Verena ;
Zoeller, Margot ;
Kissling, Sabine ;
Wenzel, Elke ;
Stutz, Nathalie ;
Freyschmidt-Paul, Pia .
EUROPEAN JOURNAL OF DERMATOLOGY, 2006, 16 (05) :537-542
[5]   CYTOKINE MESSENGER-RNA LEVELS IN ALOPECIA-AREATA BEFORE AND AFTER TREATMENT WITH THE CONTACT ALLERGEN DIPHENYLCYCLOPROPENONE [J].
HOFFMANN, R ;
WENZEL, E ;
HUTH, A ;
VANDERSTEEN, P ;
SCHAUFELE, M ;
HENNINGER, HP ;
HAPPLE, R .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1994, 103 (04) :530-533
[6]   Autoimmunity: Alopecia areata [J].
Hordinsky, M ;
Ericson, M .
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS, 2004, 9 (01) :73-78
[7]   Topical Diphencyprone as an Effective Treatment for Cutaneous Metastatic Melanoma [J].
Kim, Young Jin .
ANNALS OF DERMATOLOGY, 2012, 24 (03) :373-375
[8]   Changes in distribution pattern of CD8 lymphocytes in the scalp in alopecia areata during treatment with diphencyprone [J].
Wasyiyszyn, Tomasz ;
Koziowski, Wojciech ;
Zabielski, Stanislaw Leopold .
ARCHIVES OF DERMATOLOGICAL RESEARCH, 2007, 299 (5-6) :231-237
[9]   DIPHENYLCYCLOPROPENONE - EXAMINATION FOR POTENTIAL CONTAMINANTS, MECHANISMS OF SENSITIZATION, AND PHOTOCHEMICAL STABILITY [J].
WILKERSON, MG ;
HENKIN, J ;
WILKIN, JK .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1984, 11 (05) :802-807